Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunocore Holdings plc - American Depositary Shares (NQ: IMCR )

30.04 +0.23 (+0.79%)
Streaming Delayed Price Updated: 3:14 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 168,329
Open 29.83
Bid (Size) 29.98 (1)
Ask (Size) 30.09 (1)
Prev. Close 29.80
Today's Range 29.01 - 30.16
52wk Range 23.15 - 62.74
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Analyst Expectations For Immunocore Holdings's Future
Via Benzinga
Immunocore to present at upcoming investor conferences
From Immunocore Holdings plc
Via GlobeNewswire

Performance

YTD
+0.72%
+0.72%
1 Month
+1.33%
+1.33%
3 Month
-3.18%
-3.18%
6 Month
-6.20%
-6.20%
1 Year
-47.59%
-47.59%

More News

Read More
Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
From Immunocore Holdings plc
Via GlobeNewswire
What Analysts Are Saying About Immunocore Hldgs Stock
Via Benzinga
Earnings Scheduled For February 26, 2025
Via Benzinga
Analyst Expectations For Immunocore Hldgs's Future
Via Benzinga
Immunocore to present at upcoming investor conferences
From Immunocore Holdings plc
Via GlobeNewswire
Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
From Immunocore Holdings plc
Via GlobeNewswire
Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025
From Immunocore Holdings plc
Via GlobeNewswire
Navigating 8 Analyst Ratings For Immunocore Hldgs
Via Benzinga
A Closer Look at 9 Analyst Recommendations For Immunocore Hldgs
Via Benzinga
Analyst Ratings For Immunocore Hldgs
Via Benzinga
Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference
From Immunocore Holdings plc
Via GlobeNewswire
Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference
From Immunocore Holdings plc
Via GlobeNewswire
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development
From Immunocore Holdings plc
Via GlobeNewswire
Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAME
From Immunocore Holdings plc
Via GlobeNewswire
Immunocore announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers
From Immunocore Holdings plc
Via GlobeNewswire
Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?
Via Benzinga
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
From Immunocore Holdings plc
Via GlobeNewswire
Immunocore announces reimbursement agreement in England for KIMMTRAK▼ for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma
From Immunocore Holdings plc
Via GlobeNewswire
3 Fast-Growing Stocks Analysts See Doubling in Price
Via MarketBeat
Immunocore to present at upcoming investor conferences
From Immunocore Holdings plc
Via GlobeNewswire
Immunocore reports third quarter financial results and provides a business update
From Immunocore Holdings plc
Via GlobeNewswire
GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.